Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | April 9, 2025 |
| Shares Purchased | 877,360 |
| Highest Price Paid | 366.90 pence |
| Lowest Price Paid | 354.20 pence |
| Volume Weighted Average Price | 358.84 pence |
| Registered Share Capital | 9,033,212,761 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,028,132,556 |
Material Changes
Following the settlement of the repurchase, the number of ordinary shares with voting rights decreased to 9,028,132,556. The filing notes that 4,080,205 shares are now held as treasury shares.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital transaction.
Key Facts for Investors to Verify
- Confirmation of the total number of voting shares outstanding (9,028,132,556) for disclosure threshold calculations.
- Verification of the remaining authorization under the March 28, 2025 Buyback Programme.
- Review of the full trade breakdown available via the London Stock Exchange link provided in the filing.